Pierluigi Cortese

Creative Research Enterprises (United States)

Papers

2

Total Citations

40

H-Index

2

About

Pierluigi Cortese is a leading urologic surgeon and researcher whose work centers on the comparative effectiveness of robotic surgery for prostate and kidney cancers, with a particular focus on low-risk disease management. His most impactful contribution is a prospective randomized study comparing robot-assisted radical prostatectomy (RARP) to brachytherapy for low-risk prostate cancer, which has garnered 30 citations and provides critical evidence for treatment decision-making. Cortese also demonstrated technical innovation through his report on the first simultaneous bilateral robot-assisted partial nephrectomy (RAPN), a challenging procedure that expands the boundaries of nephron-sparing surgery. His research directly addresses the need for high-quality comparative data in an era of rapidly evolving surgical technologies, helping clinicians and patients weigh oncological control against functional outcomes. With a career dedicated to refining minimally invasive techniques and generating evidence for best practices, Cortese’s work has shaped contemporary urologic oncology, particularly in the management of low-risk prostate cancer and complex renal tumors.

Research Focus

Key Achievements

2
H-Index
2
Papers
40
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Robotic prostatectomy versus brachytherapy for the treatment of low risk prostate cancer.
30 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Creative Research Enterprises (United States)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago